C
Cytosorbents Corporation (CTSO)
NCM – Real Time Price. Currency in USD
0.59
-0.04 (-7.00%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.59
-0.04 (-7.00%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.13 | 3.40 | 10 | |
| Quick ratio | 1.58 | 2.52 | 8.0 | |
| Debt to Equity | 4.98 | 1.11 | 2.0 | |
| Debt to Assets | 0.62 | 1.58 | 3.0 | |
| Interest coverage | -5.43 | 4.33 | 1.0 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 35M | 31M | 36M | 37M | 37M |
| Gross Profit | 21M | 22M | 25M | 26M | 26M |
| Operating Income | -31M | -32M | -17M | -14M | -14M |
| Net Income | -33M | -29M | -21M | -8M | -8M |
| EBITDA | -30M | -30M | -15M | -13M | -13M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 7.71 | -150 | 3.5 |
| Next quarter | 1.9 | -266.67 | 2.0 |
| Current year | 9.52 | -30.77 | 3.5 |
| Next year | 20.91 | 64.71 | 10 |
| Weighted average score | 4.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -2.64 | -73.4 | -124.99 | -90.16 | 1.0 |
| Y/Y | 41.56 | 30.28 | 35.71 | -104.56 | 7.8 |
| 3y average | 2.75 | 33.49 | 40.36 | 27.94 | 8.5 |
| 5y average | -1.21 | -29.29 | -19.08 | -37.95 | 1.0 |
| Weighted average score | 4.6 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $29.4M significantly exceeds cash reserves ($6.2M), raising financial stability concerns
Total current assets $20.6M exceed Total current liabilities $9.7M, highlighting excellent liquidity
Debt-to-equity ratio (5.0) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-5.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.9M limits the company's ability to reinvest or pay down debt